Specialty code 183500000X · Sacramento, CA
NPI
1124178041
Since 2007
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
6600 Bruceville Rd
Sacramento, CA, 95823
Phone (916) 525-4920
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$264K
2,584 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Michelle M Lee prescribed most often to Medicare patients was Atorvastatin Calcium, with 355 prescriptions and refills. In total Michelle M Lee wrote 2,584 Medicare prescriptions that cost $264K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 355 | 1,169 | 151 | $4,319 |
| Metformin Hcl Er Metformin Hcl | 230 | 739 | 94 | $2,339 |
| Glipizide Generic | 227 | 749 | 97 | $2,813 |
| Metformin Hcl Generic | 214 | 707 | 88 | $2,899 |
| Humulin N Insulin Nph Human Isophane | 181 | 550 | 85 | $31K |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 130 | 381 | 62 | $2,896 |
| Losartan Potassium Generic | 114 | 370 | 46 | $1,528 |
| Lisinopril Generic | 98 | 326 | 46 | $1,309 |
| Jardiance Empagliflozin | 96 | 303 | 42 | $51K |
| Amlodipine Besylate Generic | 90 | 300 | 38 | $1,157 |
| Victoza 2-Pak Liraglutide | 75 | 78 | 21 | $48K |
| Insulin Glargine-Yfgn Generic | 69 | 188 | 40 | $7,527 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 68 | 195 | 32 | $1,491 |
| Humulin R Insulin Regular, Human | 66 | 197 | 32 | $11K |
| Simvastatin Generic | 58 | 193 | 22 | $677 |
Brand drugs: 671 claims; generic drugs: 1,643 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Michelle M Lee were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.